相似文献
1
Nephrogenic systemic fibrosis: a review.
J Drugs Dermatol. 2010 Jul;9(7):829-34.
2
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii66-9. doi: 10.1136/ard.2008.102475.
3
Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
Nephrol Dial Transplant. 2011 Nov;26(11):3616-26. doi: 10.1093/ndt/gfr085. Epub 2011 Mar 25.
4
Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
J Am Acad Dermatol. 2010 Feb;62(2):337-42. doi: 10.1016/j.jaad.2009.04.010. Epub 2009 Nov 24.
5
Nephrogenic systemic fibrosis: clinical picture and treatment.
Radiol Clin North Am. 2009 Sep;47(5):833-40, vi. doi: 10.1016/j.rcl.2009.05.004.
6
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503. doi: 10.1016/j.berh.2012.07.008.
7
Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
J Am Coll Cardiol. 2009 May 5;53(18):1621-8. doi: 10.1016/j.jacc.2008.12.061.
8
Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
J Cutan Pathol. 2010 Feb;37(2):204-10. doi: 10.1111/j.1600-0560.2009.01301.x.
9
Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Am J Dermatopathol. 2010 Feb;32(1):71-5. doi: 10.1097/DAD.0b013e3181b0b859.
10
The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis.
J Nephrol. 2013 Jan-Feb;26(1):48-54. doi: 10.5301/jn.5000159.
引用本文的文献
1
Role of LARP6 and nonmuscle myosin in partitioning of collagen mRNAs to the ER membrane.
PLoS One. 2014 Oct 1;9(10):e108870. doi: 10.1371/journal.pone.0108870. eCollection 2014.
2
Safety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years-a single-center, observational study.
Magn Reson Insights. 2013 Feb 6;6:1-12. doi: 10.4137/MRI.S10996. eCollection 2013.
3
A moderate response to plasmapheresis in nephrogenic systemic fibrosis.
Clin Pract. 2011 Nov 29;1(4):e124. doi: 10.4081/cp.2011.e124. eCollection 2011 Sep 28.
4
Manganese-based MRI contrast agents: past, present and future.
Tetrahedron. 2011 Nov 4;67(44):8431-8444. doi: 10.1016/j.tet.2011.07.076.
5
A novel role of vimentin filaments: binding and stabilization of collagen mRNAs.
Mol Cell Biol. 2011 Sep;31(18):3773-89. doi: 10.1128/MCB.05263-11. Epub 2011 Jul 11.
Zotero 插件